SPAR, a lncRNA encoded mTORC1 inhibitor.
a Cancer Research Institute, Beth Israel Deaconess Cancer Center , Department of Medicine and Pathology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Akinobu
A
Matsumoto
a Cancer Research Institute, Beth Israel Deaconess Cancer Center , Department of Medicine and Pathology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
John G
JG
Clohessy
a Cancer Research Institute, Beth Israel Deaconess Cancer Center , Department of Medicine and Pathology , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Pier Paolo
PP
Pandolfi
D000818:Animals; D006801:Humans; D000076222:Mechanistic Target of Rapamycin Complex 1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008954:Models, Biological; D016366:Open Reading Frames / Q000235:genetics; D062085:RNA, Long Noncoding / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
D062085:RNA, Long Noncoding; D000076222:Mechanistic Target of Rapamycin Complex 1
SPAAR; SPAR; amino acids; long non-coding RNA; mTORC1; muscle regeneration; polypeptides